BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15192153)

  • 1. Suppression of tumorigenesis by the p53 target PUMA.
    Hemann MT; Zilfou JT; Zhao Z; Burgess DJ; Hannon GJ; Lowe SW
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9333-8. PubMed ID: 15192153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
    Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
    Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1.
    Nakajima W; Tanaka N
    Biochem Biophys Res Commun; 2011 Oct; 413(4):643-8. PubMed ID: 21945433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of CDK2AP1 in primary human fibroblasts induces p53 dependent senescence.
    Alsayegh KN; Gadepalli VS; Iyer S; Rao RR
    PLoS One; 2015; 10(3):e0120782. PubMed ID: 25785833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.
    Chipuk JE; Bouchier-Hayes L; Kuwana T; Newmeyer DD; Green DR
    Science; 2005 Sep; 309(5741):1732-5. PubMed ID: 16151013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.
    Garrison SP; Jeffers JR; Yang C; Nilsson JA; Hall MA; Rehg JE; Yue W; Yu J; Zhang L; Onciu M; Sample JT; Cleveland JL; Zambetti GP
    Mol Cell Biol; 2008 Sep; 28(17):5391-402. PubMed ID: 18573879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-insensitive PUMA down-regulation is essential in the early phase of liver regeneration after partial hepatectomy in mice.
    Chen S; Zheng J; Hao Q; Yang S; Wang J; Chen H; Chen L; Zhou Y; Yu C; Jiao B; Cai Z
    J Hepatol; 2010 Jun; 52(6):864-71. PubMed ID: 20413175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PUMA-mediated apoptosis in fibroblast-like synoviocytes does not require p53.
    You X; Boyle DL; Hammaker D; Firestein GS
    Arthritis Res Ther; 2006; 8(6):R157. PubMed ID: 17014719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.
    Ito H; Kanzawa T; Miyoshi T; Hirohata S; Kyo S; Iwamaru A; Aoki H; Kondo Y; Kondo S
    Hum Gene Ther; 2005 Jun; 16(6):685-98. PubMed ID: 15960600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53-PUMA axis suppresses iPSC generation.
    Li Y; Feng H; Gu H; Lewis DW; Yuan Y; Zhang L; Yu H; Zhang P; Cheng H; Miao W; Yuan W; Cheng SY; Gollin SM; Cheng T
    Nat Commun; 2013; 4():2174. PubMed ID: 23873265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.
    Michalak EM; Jansen ES; Happo L; Cragg MS; Tai L; Smyth GK; Strasser A; Adams JM; Scott CL
    Cell Death Differ; 2009 May; 16(5):684-96. PubMed ID: 19148184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
    Lin J; Jin X; Page C; Sondak VK; Jiang G; Reynolds RK
    Cancer Res; 2000 Oct; 60(20):5895-901. PubMed ID: 11059788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
    Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts.
    Castro ME; del Valle Guijarro M; Moneo V; Carnero A
    J Cell Biochem; 2004 Jun; 92(3):514-24. PubMed ID: 15156563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting.
    D'Orazi G; Marchetti A; Crescenzi M; Coen S; Sacchi A; Soddu S
    J Gene Med; 2000; 2(1):11-21. PubMed ID: 10765501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.